Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Voyager Therapeutics (VYGR)
NASDAQ:VYGR
Voyager Therapeutics (VYGR) Stock Price & Analysis
587 Followers
VYGR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.06 - $14.34
Previous Close$8.57
Volume654.07K
Average Volume (3M)682.42K
Market Cap
$466.15M
Enterprise Value$235.28M
Total Cash (Recent Filing)$230.88M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-178.2
Beta1.02
Next Earnings
Aug 01, 2024EPS Estimate
-$0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding54,393,628
10 Day Avg. Volume462,125
30 Day Avg. Volume682,421
Standard Deviation0.22
R-Squared0.06
Alpha-0.00727
Financial Highlights & Ratios
Price to Book (P/B)1.95
Price to Sales (P/S)5.18
Price to Cash Flow (P/CF)-4.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.94
Enterprise Value/Gross Profit0.94
Enterprise Value/Ebitda1.25
Forecast
1Y Price Target
$17.50Price Target Upside102.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Voyager Therapeutics News
Ownership Overview
44.22% Insiders
12.54% Mutual Funds
38.37% Other Institutional Investors
4.87% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VYGR FAQ
What was Voyager Therapeutics’s price range in the past 12 months?
Voyager Therapeutics lowest stock price was $6.06 and its highest was $14.34 in the past 12 months.
What is Voyager Therapeutics’s market cap?
Currently, no data Available
When is Voyager Therapeutics’s upcoming earnings report date?
Voyager Therapeutics’s upcoming earnings report date is Aug 01, 2024 which is in 77 days.
How were Voyager Therapeutics’s earnings last quarter?
Voyager Therapeutics released its earnings results on May 13, 2024. The company reported -$0.2 earnings per share for the quarter, beating the consensus estimate of -$0.439 by $0.239.
Is Voyager Therapeutics overvalued?
According to Wall Street analysts Voyager Therapeutics’s price is currently Undervalued.
Does Voyager Therapeutics pay dividends?
Voyager Therapeutics does not currently pay dividends.
What is Voyager Therapeutics’s EPS estimate?
Voyager Therapeutics’s EPS estimate is -$0.41.
How many shares outstanding does Voyager Therapeutics have?
Voyager Therapeutics has 54,393,627 shares outstanding.
What happened to Voyager Therapeutics’s price movement after its last earnings report?
Voyager Therapeutics reported an EPS of -$0.2 in its last earnings report, beating expectations of -$0.439. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Voyager Therapeutics?
Among the largest hedge funds holding Voyager Therapeutics’s share is Farallon Capital Management, L.L.C.. It holds Voyager Therapeutics’s shares valued at 12M.
---
Voyager Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$17.50 (102.78% Upside)
$17.50 (102.78% Upside)
Blogger Sentiment
Bullish
VYGR Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 10.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $317.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.4%
Last 30 Days ▲ 9.4%
Last 30 Days ▲ 9.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.59%
12-Months-Change
Fundamentals
Return on Equity
-1.09%
Trailing 12-Months
Asset Growth
39.64%
Trailing 12-Months
Company Description
Voyager Therapeutics
Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene theraphy programs include VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guangping Gao, Mark A. Kay, Krystof Bankiewicz and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.
---
VYGR Earnings Call
Q1 2024
0:00 / 0:00
---
VYGR Stock 12 Month Forecast
Average Price Target
$17.50
▲(102.78% Upside)
Technical Analysis
Best Analysts Covering VYGR
1 Year
1 Year Success Rate
10/15 ratings generated profit
1 Year Average Return
+16.25%
reiterated a buy rating 3 days ago
Copying Jack Allen's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +16.25% per trade.
---